EUVIMEDEUVIMED entdecken
Crossref

Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population

Kanchi Rama iD, Aparna R Bitla iD, Narendra Hulikal iD, Mutheeswaraiah Yootla iD, Lakshmi Amancharla Yadagiri iD, T Asha iD, M Manickavasagam iD, Pvln Srinivasa Rao iD

Indian Journal of Cancer · 2024-04 · 61 (2) · 290-298

DOI: 10.4103/ijc.ijc_187_20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Cancer, online erschienen am 17.07.2023. Verfasst von Kanchi Rama und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Biomarkers, Tumor, Neoplasm Staging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Current markers (carcinoembryonic antigen [CEA] and carbohydrate antigen 15-3 [CA15-3]) lack sensitivity in diagnosis of breast cancer. The aberrantly expressed circulating miRNAs were shown as diagnostic markers in breast cancer. However, there are very few studies from the Indian population. We studied the diagnostic utility of miRNA-21, miRNA-155 and miRNA-205 compared to CEA and CA15-3 in stage I and II breast cancer patients. Materials and Methods: Sixty newly diagnosed women with stage I/II breast cancer and 20 healthy controls were recruited. Expression of circulating miRNAs was studied using reverse transcription-polymerase chain reaction, whereas CEA and CA 15-3 were analyzed by enzyme-linked immunosorbent assay. Results: miRNA-21 and miRNA-155 were upregulated, miRNA-205 down-regulated ( P < 0.05) and serum CEA and CA15-3 levels increased in breast cancer patients ( P < 0.001). Receiver operating characteristic curve analysis showed significant area under curve (AUC) for all markers (0.656 to 0.993; P = 0.015 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsBiomarkers, TumorNeoplasm StagingMucin-1HumansFemaleMiddle AgedIndiaAdultCarcinoembryonic AntigenAgedCase-Control Studies

Substanzen

MicroRNAsBiomarkers, TumorMucin-1Carcinoembryonic AntigenMIRN21 microRNA, humanMIR205, human

Autor:innen und Institutionen

  • Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
  • Department of Surgical Oncology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
  • Department of Surgery, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
  • Department of Radiology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
  • Department of Pathology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
  • Department of Medical Oncology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.

ORCID-Profile: Kanchi Rama, Aparna R Bitla, Narendra Hulikal, Mutheeswaraiah Yootla, Lakshmi Amancharla Yadagiri, T Asha, M Manickavasagam, Pvln Srinivasa Rao

Zitieren

APA

Rama, K., Bitla, A. R., Hulikal, N., Yootla, M., Yadagiri, L. A., Asha, T., Manickavasagam, M., & Srinivasa Rao, P. (2024). Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population. Indian Journal of Cancer, 61(2), 290-298. https://doi.org/10.4103/ijc.ijc_187_20

Vancouver

Rama K, Bitla AR, Hulikal N, Yootla M, Yadagiri LA, Asha T, et al. Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population. Indian Journal of Cancer. 2024;61(2):290-298. doi:10.4103/ijc.ijc_187_20

BibTeX
@article{Rama2024,
  author = {Rama, Kanchi and Bitla, Aparna R and Hulikal, Narendra and Yootla, Mutheeswaraiah and Yadagiri, Lakshmi Amancharla and Asha, T and Manickavasagam, M and Srinivasa Rao, Pvln},
  title = {Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population},
  journal = {Indian Journal of Cancer},
  year = {2024},
  volume = {61},
  number = {2},
  pages = {290--298},
  doi = {10.4103/ijc.ijc_187_20}
}
Kostenlos starten →